Inga Peter, PhD
img_Inga Peter
PROFESSOR | Genetics and Genomic Sciences
Research Topics
Cardiovascular, Genetics, Genomics, Human Genetics and Genetic Disorders, Inflammatory Bowel Disease (IBD), Microbiology
Multi-Disciplinary Training Area
Genetics and Genomic Sciences [GGS]

MSc, Tel Aviv University

PhD, Tel Aviv University

Postdoc, Tufts University

Publications

Selected Publications

The landscape of rare genetic variation associated with inflammatory bowel disease and Parkinson’s disease comorbidity. Meltem Ece Kars, Yiming Wu, Peter D. Stenson, David N. Cooper, Johan Burisch, Inga Peter, Yuval Itan. Genome Medicine

Micro- and nano-plastics, intestinal inflammation, and inflammatory bowel disease: A review of the literature. Manasi Agrawal, Alvise Vianello, Mellissa Picker, Laura Simon-Sánchez, Rosemary Chen, Maria Manuela Estevinho, Kaitlyn Weinstein, Jeanette Lykkemark, Tine Jess, Inga Peter, Jean Frederic Colombel, Kristine Højgaaard Allin, Jes Vollertsen. Science of the Total Environment

Human Leukocyte Antigen Signatures as Pathophysiological Discriminants of Microscopic Colitis Subtypes. Tenghao Zheng, Giulia Roda, Yamile Zabana, Celia Escudero-Hernández, Xingrong Liu, Ye Chen, Leticia Camargo Tavares, Ferdinando Bonfiglio, Marie Rose Mellander, Izabella Janczewska, Lina Vigren, Klas Sjöberg, Bodil Ohlsson, Sven Almer, Jonas Halfvarson, Stephan Miehlke, Ahmed Madisch, Wolfgang Lieb, Juozas Kupčinskas, Rinse K. Weersma, Luis Bujanda, Antonio Julià, Sara Marsal, Maria Esteve, Danila Guagnozzi, Fernando Fernández-Bañares, Carmen Ferrer, Inga Peter, Jonas F. Ludvigsson, Darrell Pardi, Bas Verhaegh, Daisy Jonkers, Marieke Pierik, Andreas Münch, Andre Franke, Francesca Bresso, Hamed Khalili, Jean Frederic Colombel, Mauro D’Amato, Lance Presser, Anne Teirlinck, Mirjam Knol, Marta Piqueras, David Busquets, Eva Iglesias, Alfredo J. Lucendo. Journal of Crohn's and Colitis

View All Publications

Faculty Spotlight: Inga Peter, PhD

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Dr. Peter has not yet completed reporting of Industry relationships.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.